---
title: Polymyalgia rheumatica
---
# Polymyalgia rheumatica

(JAMA 2016;315:2442; Lancet 2017;390:1700)
- Prev 7/1000 of age ≥50.
- In 50% of GCA Pts; 15% of PMR Pts develop GCA. ♀:♂ ≈ 2.
- ESR >40 mm/h (and/or ↑ CRP);

## clinical manifestations
* bilateral pain & morning stiffness (>30 min),
* involving 2 of 3 areas:
	* neck or torso, shoulders or prox arms, hips or prox. thighs;
	* nighttime pain;
	* ± subdeltoid bursitis on U/S;
* exclude other causes of sx (eg, RA); nl CK

## treatment
* pred 12.5–25 mg/d;
	* if clinical response,
		* initiate slow taper.
	* If not,
		* consider alternate dx or ↑ dose.
* Consider MTX if at ↑ risk of steroid side effects
(Ann Rheum Dis 2015;74:1799).
